Authors:
Cascinelli, N
Belli, F
MacKie, RM
Santinami, M
Bufalino, R
Morabito, A
Citation: N. Cascinelli et al., Effect of long-term adjuvant therapy with interferon alpha-2a in patients with regional node metastases from cutaneous melanoma: a randomised trial, LANCET, 358(9285), 2001, pp. 866-869
Authors:
Brownbridge, GG
Gold, J
Edward, M
MacKie, RM
Citation: Gg. Brownbridge et al., Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled-polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma, BR J DERM, 144(2), 2001, pp. 279-287
Authors:
Morton, CA
Whitehurst, C
McColl, JH
Moore, JV
MacKie, RM
Citation: Ca. Morton et al., Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma, ARCH DERMAT, 137(3), 2001, pp. 319-324
Authors:
Cascinelli, N
Belli, F
Santinami, M
Fait, V
Testori, A
Ruka, W
Cavaliere, R
Mozzillo, N
Rossi, CR
MacKie, RM
Nieweg, O
Pace, M
Kirov, K
Citation: N. Cascinelli et al., Sentinel lymph node biopsy in cutaneous melanoma: The WHO Melanoma Programexperience, ANN SURG O, 7(6), 2000, pp. 469-474
Authors:
Richard, G
Brown, N
Smith, LE
Terrinoni, A
Melino, G
MacKie, RM
Bale, SJ
Uitto, J
Citation: G. Richard et al., The spectrum of mutations in erythrokeratodermias - novel and de novo mutations in GJB3, HUM GENET, 106(3), 2000, pp. 321-329
Authors:
Morton, CA
Whitehurst, C
Moore, JV
MacKie, RM
Citation: Ca. Morton et al., Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy, BR J DERM, 143(4), 2000, pp. 767-772
Citation: Cs. Jury et al., Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma, BR J DERM, 143(2), 2000, pp. 269-274
Citation: Cl. Alexander et al., Effect of retinoic acid on plasminogen activator expression in human melanoma cells, MELANOMA RE, 9(4), 1999, pp. 360-367
Citation: Cl. Alexander et al., Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis, MELANOMA RE, 9(1), 1999, pp. 31-39
Citation: Jl. Godden et al., Melanoma cell-derived factor stimulation of fibroblast glycosaminoglycan synthesis - The role of platelet-derived growth factor, EUR J CANC, 35(3), 1999, pp. 473-480
Authors:
Cree, IA
Neale, MH
Myatt, NE
de Takats, PG
Hall, P
Grant, J
Kurbacher, CM
Reinhold, U
Neuber, K
MacKie, RM
Chana, J
Weaver, PC
Khoury, GG
Sartori, C
Andreotti, PE
Citation: Ia. Cree et al., Heterogeneity of chemosensitivity of metastatic cutaneous melanoma, ANTI-CANC D, 10(5), 1999, pp. 437-444
Authors:
Gupta, G
Morton, CA
Whitehurst, C
Moore, JV
MacKie, RM
Citation: G. Gupta et al., Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topicaltreatment of Bowen's disease and basal cell carcinoma, BR J DERM, 141(2), 1999, pp. 385-386
Citation: Cl. Alexander et al., The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid, BR J CANC, 80(10), 1999, pp. 1494-1500
Authors:
Burden, AD
Newell, J
Andrew, N
Kavanagh, G
Connor, JM
MacKie, RM
Citation: Ad. Burden et al., Genetic and environmental influences in the development of multiple primary melanoma, ARCH DERMAT, 135(3), 1999, pp. 261-265